These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22665147)

  • 41. Alleviation of pain and symptoms with a life-shortening intention.
    van Bruchem-van de Scheur GA; van der Arend AJ; Abu-Saad HH; van Wijmen FC; Spreeuwenberg C; ter Meulen RH
    Nurs Ethics; 2008 Sep; 15(5):682-95. PubMed ID: 18687821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decision making for the critically ill neonate near the end of life.
    Cook LA; Watchko JF
    J Perinatol; 1996; 16(2 Pt 1):133-6. PubMed ID: 8732563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Spinal muscular atrophy and respiratory failure. How do primary care pediatricians act in a simulated scenario?].
    Agra Tuñas MC; Sánchez Santos L; Busto Cuiñas M; Rodríguez Núñez A
    An Pediatr (Barc); 2015 Nov; 83(5):336-40. PubMed ID: 25804552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matters of spirituality at the end of life in the pediatric intensive care unit.
    Robinson MR; Thiel MM; Backus MM; Meyer EC
    Pediatrics; 2006 Sep; 118(3):e719-29. PubMed ID: 16950963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Withdrawal and limitation of life-sustaining treatments in a paediatric intensive care unit and review of the literature.
    Moore P; Kerridge I; Gillis J; Jacobe S; Isaacs D
    J Paediatr Child Health; 2008; 44(7-8):404-8. PubMed ID: 18638332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epidemiology of decision on life-sustaining treatment in the general internal medicine division].
    Sonnenblick M; Gratch L; Raveh D; Steinberg A; Yinnon AM
    Harefuah; 2003 Oct; 142(10):650-3, 720. PubMed ID: 14565058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hammersmith functional rating scale for children with spinal muscular atrophy. Validation of the Spanish version].
    Febrer A; Vigo M; Fagoaga J; Medina-Cantillo J; Rodríguez N; Tizzano E
    Rev Neurol; 2011 Dec; 53(11):657-63. PubMed ID: 22086427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limitation of treatment at the end of life: an empirical-ethical analysis regarding the practices of physician members of the German Society for Palliative Medicine.
    Schildmann J; Hoetzel J; Baumann A; Mueller-Busch C; Vollmann J
    J Med Ethics; 2011 Jun; 37(6):327-32. PubMed ID: 21292698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory support for the severely handicapped child with neuromuscular disease: ethics and practicality.
    Simonds AK
    Semin Respir Crit Care Med; 2007 Jun; 28(3):342-54. PubMed ID: 17562504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating end of life practices in ten Brazilian paediatric and adult intensive care units.
    Piva J; Lago P; Othero J; Garcia PC; Fiori R; Fiori H; Borges LA; Dias FS
    J Med Ethics; 2010 Jun; 36(6):344-8. PubMed ID: 20439333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Passage to Paradise" ethics and end-of-life decisions in children.
    Puckey M; Bush A
    Paediatr Respir Rev; 2011 Jun; 12(2):139-43. PubMed ID: 21458743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential impact of decision role and patient age on end-of-life treatment decision making.
    Zikmund-Fisher BJ; Lacey HP; Fagerlin A
    J Med Ethics; 2008 May; 34(5):327-31. PubMed ID: 18448709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Legal and Ethical Analysis of the Effects of Triggering Conditions on Surrogate Decision-Making in End-of-Life Care in the US.
    Clint Parker J; Goldberg DS
    HEC Forum; 2016 Mar; 28(1):11-33. PubMed ID: 26084270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reconceiving Decisions at the End of Life in Pediatrics: Decision-Making as a Form of Ritual.
    Caruso Brown AE
    Perspect Biol Med; 2019; 62(2):301-318. PubMed ID: 31281123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidisciplinary approach and psychosocial management of spinal muscular atrophy (SMA).
    Ropars J; Peudenier S; Genot A; Barnerias C; Espil C
    Arch Pediatr; 2020 Dec; 27(7S):7S45-7S49. PubMed ID: 33357598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethical content of expert recommendations for end-of-life decision-making in intensive care units: A systematic review.
    Spoljar D; Curkovic M; Gastmans C; Gordijn B; Vrkic D; Jozepovic A; Vuletic S; Tonkovic D; Borovecki A
    J Crit Care; 2020 Aug; 58():10-19. PubMed ID: 32278227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethics consultation in pediatrics: long-term experience from a pediatric oncology center.
    Johnson LM; Church CL; Metzger M; Baker JN
    Am J Bioeth; 2015; 15(5):3-17. PubMed ID: 25970382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What Matters Most: A Perspective From Adult Spinal Muscular Atrophy Patients.
    Hunter M; Heatwole C; Luebbe E; Johnson NE
    J Neuromuscul Dis; 2016 Aug; 3(3):425-429. PubMed ID: 27854231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Relational Potential Standard: Rethinking the Ethical Justification for Life-Sustaining Treatment for Children with Profound Cognitive Disabilities.
    Wightman A; Kett J; Campelia G; Wilfond BS
    Hastings Cent Rep; 2019 May; 49(3):18-25. PubMed ID: 31269258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The modern minor: consent and decision-making in pediatric dermatology.
    Wolz MM
    J Am Acad Dermatol; 2013 Dec; 69(6):1043-5. PubMed ID: 24238157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.